2022 annual financial data
Marker Therapeutics 2022 Financial results
Direct answer
Revenue was 3,513,544 USD.
Operating income was -19,791,004 USD and net income was -29,930,694 USD.
Operating cash flow was -26,972,153 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,513,544 USD
- Operating income
- -19,791,004 USD
- Net income
- -29,930,694 USD
- Operating cash flow
- -26,972,153 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Marker Therapeutics financial years